Common Names
Geographic Range: Northern China, Mongolia, Central Asia. Arid steppes and desert margins.
Known Contraindications
1
Compounds
2
Traditions
2
Treatments
1
Conditions
CN[C@@H](C)[C@H](O)c1ccccc1CYP Interaction Profile
| Enzyme | Interaction |
|---|---|
| CYP1A2 | no significant interaction |
| CYP2C9 | no significant interaction |
| CYP2D6 | weak substrate (minor N-demethylation) |
| CYP3A4 | no significant interaction |
| CYP2C19 | no significant interaction |
| renal_note | Primarily renally excreted unchanged (55-75%). Urinary pH-dependent: acidic urine accelerates excretion. |
| clinical_note | DANGEROUS with MAOIs (hypertensive crisis risk). Additive with caffeine, theophylline, other sympathomimetics. Restricted/banned substance in many jurisdictions. |